标题
Myxofibrosarcoma primary cultures: molecular and pharmacological profile
作者
关键词
-
出版物
Therapeutic Advances in Medical Oncology
Volume 9, Issue 12, Pages 755-767
出版商
SAGE Publications
发表日期
2017-10-28
DOI
10.1177/1758834017737472
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
- (2017) Federica Recine et al. OncoTargets and Therapy
- Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
- (2016) A. Gronchi et al. ANNALS OF ONCOLOGY
- Surgical margins do not affect prognosis in high grade myxofibrosarcoma
- (2016) A. Sambri et al. EJSO
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
- (2016) Alessandro De Vita et al. MOLECULES
- Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
- (2016) Alessandro De Vita et al. OncoTargets and Therapy
- Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
- (2016) Bo-Gen Ye et al. Oncotarget
- Innovative approaches to establish and characterize primary cultures: anex vivo3D system and the zebrafish model
- (2016) Chiara Liverani et al. Biology Open
- Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro
- (2016) Giovanna Calabrese et al. PLoS One
- Soluble CD109 binds TGF- and antagonizes TGF- signalling and responses
- (2015) C. Li et al. BIOCHEMICAL JOURNAL
- TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
- (2015) Naoki Oshimori et al. CELL
- Prognostic impact of CD109 expression in myxofibrosarcoma
- (2015) Makoto Emori et al. JOURNAL OF SURGICAL ONCOLOGY
- Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
- (2015) Rita De Sanctis et al. Drug Design Development and Therapy
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Multiscale Patterning of a Biomimetic Scaffold Integrated with Composite Microspheres
- (2014) Silvia Minardi et al. Small
- CD109 is a potential target for triple-negative breast cancer
- (2014) Ji Tao et al. TUMOR BIOLOGY
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
- (2013) Makoto Emori et al. PLoS One
- Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma
- (2012) Nicole J. Look Hong et al. ANNALS OF SURGICAL ONCOLOGY
- The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors
- (2011) Albane A. Bizet et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution
- (2010) Alessandro Gronchi et al. ANNALS OF SURGERY
- Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution
- (2010) Roberta Sanfilippo et al. ANNALS OF SURGICAL ONCOLOGY
- Establishment of a primary human sarcoma model in athymic nude mice
- (2010) Lars STEINSTRAESSER et al. Human Cell
- Recurrence Patterns and Survival for Patients With Intermediate- and High-Grade Myxofibrosarcoma
- (2010) Karl E. Haglund et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Processing of CD109 by furin and its role in the regulation of TGF-β signaling
- (2010) S Hagiwara et al. ONCOGENE
- Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering
- (2009) Gráinne M. Cunniffe et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma
- (2008) Yoshiaki Hagiwara et al. CANCER SCIENCE
- Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma
- (2008) Shailendra Verma et al. CANCER TREATMENT REVIEWS
- Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms
- (2008) Joshua Weaver et al. MODERN PATHOLOGY
- CD109 expression in basal-like breast carcinoma
- (2008) Masaki Hasegawa et al. PATHOLOGY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now